This systematic review offers a comprehensive and detailed comparison of the efficacy and long-term outcomes of four major pharmacological treatments (SGLT2 inhibitors, DPP-4 inhibitors, metformin, and insulin) in the management of T2DM. Here, DPP4 is linked to type 2 diabetes mellitus.